Delivery Order SPE2DB24D3013-SPE2DB26FFFSS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,989.35 to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with completion scheduled for July 22, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.86 to AmerisourceBergen Drug Corp for Copaxone 20 mg/ml syringes, with a completion date of August 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operates as a major...
- The Defense Logistics Agency awarded a delivery order valued at $10,510.43 to AmerisourceBergen Drug Corp for the supply of Copaxone 20 mg/ml syringes. The contract, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, carries firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed...
- The Defense Logistics Agency awarded a $1,092.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with a completion date of September 11, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,580.20 to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, utilizes firm fixed price terms and was competitively awarded without set-aside provisions. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is...
- The Defense Logistics Agency awarded a $15,154.14 delivery order to AmerisourceBergen Drug Corp for the supply of Copaxone 20 mg/ml syringes. The contract, which was competitively awarded without set-aside designation, became effective on April 21, 2025, with an ultimate completion date of April 22, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a firm fixed-price delivery order, this award represents a discrete fulfillment...
- The Defense Logistics Agency awarded a delivery order valued at $6,202.79 to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with an ultimate completion date of September 18, 2025. This is a firm fixed price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal procurement relationship supporting military and federal healthcare systems....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/mL syringes under a firm fixed-price contract with a ceiling value of $1,128.54. This non-set-aside award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a direct delivery order fulfillment. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Copaxone 40 mg/mL syringes with a firm fixed price ceiling value of $2,645.73. This is a non-set-aside competitive award, reflecting AmerisourceBergen's qualification to compete openly for federal medical procurement needs. The delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $4,368 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFSSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,522.65 to AmerisourceBergen Drug Corp for the supply of Copaxone 20 mg/mL syringes. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 22, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor in the federal medical procurement supply chain, particularly for military and veteran healthcare systems. The parent IDC vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. This specific delivery order for Copaxone, a medication used to treat multiple sclerosis, represents one of numerous pharmaceutical deliveries the company fulfills under its expansive DLA contract portfolio, which demonstrates its capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 10/21/25 |